Pretreatment with dithiothreitol (DTT) is necessary to dissolve mucus in sa
mples of induced sputum prior to analysis. However, DTT may affect cell sur
face markers which are essential for lymphocyte subtyping. Therefore, the a
im of this study was: to evaluate the effect of DTT on an appropriate panel
of surface markers. Peripheral blood leukocytes were used because these ce
lls, in contrast to sputum cells, could be obtained without DTT treatment.
Peripheral blood from healthy donors was incubated with either DTT accordin
g to standard sputum procedures or phosphate-buffered saline (PBS), washed
and incubated with fluorochrome-labelled antibodies. After lysis of erythro
cytes, analysis was performed using a calibrated flow cytometer. Leukocyte
populations were identified by their Light scattering properties. For analy
sis, fluorescence intensity was compared between DTT- and PBS-treated sampl
es.
After treatment with DTT, fluorescence intensity was significantly increase
d in CD16-positive granulocytes; it was reduced in CD2-positive lymphocytes
, CD45-positive lymphocytes and CD14-positive monocytes (p less than or equ
al to 0.001). These changes occurred in all samples. The fluorescence inten
sity of CD3-, CD4-, CD8-, CD19-, CD56- and histocompatibility leukocyte ant
igen DR-positive lymphocytes was not altered by DTT. However, there were st
atistically significant (p < 0.001), although small, changes in the percent
ages of leukocytes.
The present data demonstrate that, although dithiothreitol as used in sputu
m analysis affects some surface markers of peripheral blood leukocytes, com
parability between samples concerning lymphocyte surface markers is preserv
ed. Therefore, it is suggested that treatment of sputum samples with dithio
threitol does not invalidate the immunocytochemical analysis of lymphocytes
.